Mad in America

JANUARY 4, 2025

All of the ingredients for a blockbuster article were now clearly visible, including an acknowledgement from inside psychiatry that this story was of profound importance for all of our society. Yet, the media has remained silent, and now the scandal is fading away.

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

JANUARY 3, 2024

The article, written by John Miller, editor-in-chief of Psychiatric Times , prompted readers to consider the possible extraordinary harm done. Here is the cover from that issue: In his essay, Miller repeatedly stressed that ever since 2006, the STAR*D study had stood “out as a beacon guiding treatment decisions.”

Neurotransmitters and mental health 144

Neurotransmitters and mental health Hospitality Education Self-awareness 144

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145